The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.111%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 19.00
STCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

26 Sep 2022 07:00

RNS Number : 5825A
Steppe Cement Limited
26 September 2022
 

 

 

Steppe Cement Ltd

Interim Results for the Half Year ended 30 June 2022

and General Market Update

1. Interim Results

Steppe Cement Ltd ("Steppe Cement" and "the Company") posted a consolidated profit after tax of USD10.2 million for the six months ended 30 June 2022, an increase of 65% over the corresponding period for the previous year.

 

6 months

ended

30 June 22

6 months

ended

30 June 21

% of change

Sales (Tonnes)

837,063

840,661

0%

Consolidated turnover KZT million

19,779

16,657

19%

Consolidated turnover (USD million)

43.1

39.5

9%

Consolidated profit after tax (USD million)

10.2

6.2

65%

Earnings per share (Cents)

4.7

2.8

47%

Average exchange rate (USD/KZT)

449

424

-6%

 

· The Company managed to increase prices in the first during the first half of 2022, with the average ex-factory price achieved increasing from 16,571 KZT /tonne (USD39 per tonne) to 20,485 KZT/tonne (USD 45 per tonne) or 18% compared with first half 2021.

· Steppe Cement's gross margin increased from 44% to 46% in USD terms compared with first half 2021 due to the price increases.

· Selling expenses per tonne decreased in USD terms by 20% compared with the corresponding period in 2021 primarily due to increased sales to markets closer to the factory.

· Administrative expenses increased by 7% in USD terms compared with first half of 2021.

· On average, the Kazakh Tenge depreciated by 6% compared to the first half of 2021 but only translated in a small foreign exchange loss of USD 0.2 million.

· The Company generated operating profit before working capital changes of USD 16.3 million in 1H 2022 against USD 12.9 million in the corresponding period for 2021.

· Kazakhstan GDP increased by 3.4% in the first half of 2022 compared to the first half of 2021. In the first quarter of 2022 the GDP growth was 4.6% despite the January and February local and international instability.

· Reported inflation has been 15% up to the end of June 2022.

2. Production and capex

· Production costs increased by 11% in KZT in the first half of 2022 primarily due to the higher electricity cost, diesel and spare parts for maintenance.

· The separator of cement mill number 1 has been commissioned and work has started in the separator of cement mill number 2.

3. Update on the Kazakh cement market

· The Kazakh cement market increased by 2% during the first half of the year as the government has maintained its incentives for construction.

· Steppe Cement maintained its local market share at 14.5% in 1H2022. We expect to maintain or increase this share for the full year.

· Exports at 0.54 million tonnes represented 10% of the volumes in the 1H2022 from 9% last year.

· Imports into Kazakhstan have been decreased to 0.35 million tonnes in 2022 and represent 6% of the market.

· Overall production of all factories in Kazakhstan has decreased by 0.4 million tonnes to 4.8 million tonnes for the 1H2022 as reductions in bigger factories were balanced by increased volumes in Gezhuoba and Alacem.

· Currently 82% of production in the country is manufactured from dry lines a similar figure than last year.

 

4. Finance

· Interest expenses on bank debt reduced to USD 0.2 million from USD 0.3 million in 2021 mostly on subsidised loans while we maintained interest expenses on lease liabilities at USD 0.1 million after to the application of IFRS 16 on the 3-year wagon leases. The rental on those wagons was previously treated as selling expenses. The contract to rent wagons is due for renewal in in the second half of 2022.

· Steppe Cement recorded a net cash position of USD9.3 million compared to net cash of USD7.4 million as of 30 June 2021.

· The borrowings of the Company as of 30 June 2022 were USD5.4 million while we carried a cash balance of USD14.7 million. For comparison, on 30 June 2021 the Company had USD6.1 million of borrowings and USD13.5 million in cash.

· Pursuant to the announcement of the Company on 13 June 2022, the Company has reserved GBP11 million in cash (5p/share) for payment to shareholders through a dividend or alternative process such as a capital return, in respect of the results for the full year ended 31 December 2021. The approach to be taken on how to proceed with payment of this amount to shareholders in the most tax effective way remains under consideration, however, the Company anticipates an announcement regarding this distribution and its timing will be made in November. 

 

A pdf copy of the announcement and the full interim financial statements is available on the company's website at www.steppecement.com.

 

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser: Contact Stephen Allen or Andrew Thomson at +61 8 9480 2500.

Broker: Contact Charlie Cryer at +44 20 3440 6800

SUMMARY OF INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 JUNE 2022 (UNAUDITED)

(In United States Dollars)

 

The Notes to the Interim Financial Statements form an integral part of the Condensed Financial Statements. Please visit the Company's website at www.steppecement.com to view the full interim financial statements.

 

STEPPE CEMENT LTD

(Incorporated in Labuan FT, Malaysia under the Labuan Companies Act, 1990)

AND ITS SUBSIDIARY COMPANIES

 

CONDENSED CONSOLIDATED STATEMENT OF PROFIT AND LOSS

FOR THE PERIOD ENDED 30 JUNE 2022 (UNAUDITED)

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2022

30 June 2021

30 June 2022

30 June 2021

USD'000

USD'000

USD'000

USD'000

Revenue

43,125

39,534

670

691

Cost of sales

(23,148)

(22,082)

-

-

Gross profit

19,977

17,452

670

691

Selling expenses

(5,285)

(6,577)

-

-

General and administrative

expenses

(3,183)

(2,965)

(165)

(157)

Operating profit

11,509

7,910

505

534

Interest income

266

78

-

-

Finance costs

(435)

(475)

-

-

Net foreign exchange (loss)/gain

(246)

(147)

3

(1)

Other income, net

940

341

-

-

Profit before income tax

12,034

7,707

508

533

Income tax expense

(1,831)

(1,515)

-

-

Profit for the period

10,203

6,192

508

533

Attributable to:

Shareholders of the Company

10,203

6,192

508

533

Earnings per share:

Basic and diluted (cents)

4.7

2.8

 

^ Insignificant amount.

 

 

CONDENSED CONSOLIDATED STATEMENT OF PROFIT AND LOSS AND OTHER COMPREHENSIVE INCOME FOR THE PERIOD ENDED 30 JUNE 2022 (UNAUDITED)

 

 

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2022

30 June 2021

30 June 2022

30 June 2021

USD'000

USD'000

USD'000

USD'000

Profit for the period

10,203

6,192

508

533

Other comprehensive loss:

 

Item that may be reclassified subsequently to profit or loss

Exchange differences arising on translation of foreign subsidiary companies

(4,941)

(902)

-

-

Total other comprehensive loss for the period

(4,941)

(902)

-

-

Total comprehensive income for the period

5,262

5,290

508

533

Attributable to:

Shareholders of the Company

5,262

5,290

508

533

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2022 (UNAUDITED)

 

 

The Group

The Company

Unaudited

Audited

Unaudited

Audited

30 June 2022

31 Dec 2021

30 June 2022

31 Dec 2021

USD'000

USD'000

USD'000

USD'000

Assets

Non-Current Assets:

Property, plant and equipment

44,599

48,438

-

-

Right-of-use assets

792

1,700

Investment in subsidiary companies

-

-

36,200

36,200

Loan to subsidiary company

-

-

30,114

30,080

Advances

6

-

-

-

Other assets

161

155

-

-

Total Non-Current Assets

45,558

50,293

66,314

66,280

Current Assets

Inventories

17,356

16,024

-

-

Trade and other receivables

4,544

1,752

1,265

1,724

Other assets

2,076

2,258

-

-

Income tax receivable

846

911

-

-

Loans and advances to subsidiaries companies

-

-

39

50

Advances and prepaid expenses

8,439

5,234

17

5

Cash and cash equivalents

14,694

10,136

1,602

614

Total Current Assets

47,955

36,315

2,923

2,393

Total Assets

93,513

86,608

69,237

68,673

 

The Group

The Company

Unaudited

Audited

Unaudited

Audited

30 June 2022

31 Dec 2021

30 June 2022

31 Dec 2021

USD'000

USD'000

USD'000

USD'000

Equity and Liabilities

Capital and Reserves

Share capital

73,761

73,761

73,761

73,761

Revaluation reserve

1,931

2,068

-

-

Translation reserve

(125,379)

(120,438)

-

-

Retained earnings

120,530

110,190

(5,098)

(5,606)

Total Equity

70,843

65,581

68,663

68,155

Non-Current Liabilities

Borrowings

3,621

1,941

-

-

Lease liabilities

4

9

-

-

Deferred taxes

3,654

4,319

-

-

Deferred income

1,868

1,588

-

-

Provision for site restoration

172

180

-

-

Total Non-Current Liabilities

9,319

8,037

-

-

Current liabilities

Trade and other payables

5,803

5,062

-

-

Accrued and other liabilities

3,369

1,553

284

228

Amount due to subsidiary company

-

-

290

290

Borrowings

1,807

3,615

-

-

Lease liabilities

966

2,018

-

-

Deferred income

100

103

-

-

Taxes payable

1,306

639

-

-

Total Current Liabilities

13,351

12,990

574

518

Total Liabilities

22,670

21,027

574

518

Total Equity and Liabilities

93,513

86,608

69,237

68,673

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 30 JUNE 2022 (UNAUDITED)

 

 

Non-distributable

Distributable

The Group

Share capital

Revaluation reserve

Translation reserve

Retained earnings

Total

USD'000

USD'000

USD'000

USD'000

USD'000

Balance as at 1 January 2022

73,761

2,068

(120,438)

110,190

65,581

Profit for the period

-

-

-

10,203

10,203

Other comprehensive loss

-

-

(4,941)

-

(4,941)

Total comprehensive income for the period

-

-

(4,941)

10,203

5,262

Transfer of revaluation reserve relating to the depreciation of property, plant and equipment through use

-

(137)

-

137

-

Balance as at 30 June 2022

73,761

1,931

(125,379)

120,530

70,843

 

 

 

 

 

Non-distributable

Distributable

The Group

Share capital

Revaluation reserve

Translation reserve

Retained earnings

Total

USD'000

USD'000

USD'000

USD'000

USD'000

Balance as at 1 January 2021

73,761

2,370

(118,514)

100,325

57,942

Profit for the period

-

-

-

6,192

6,192

Other comprehensive loss

-

-

(902)

-

(902)

Total comprehensive income/(loss) for the period

-

-

(902)

6,192

5,290

Transfer of revaluation reserve relating to the depreciation of property, plant and equipment through use

-

(148)

-

148

-

Balance as at 30 June 2021

73,761

2,222

(119,416)

106,665

63,232

 

 

The Company

Share capital

(Accumulated losses)/ Retained earnings

Total

USD'000

USD'000

USD'000

Balance as at 1 January 2022

73,761

(5,606)

68,155

Total comprehensive income for the period

-

508

508

Balance as at 30 June 2022

73,761

(5,098)

68,663

Balance as at 1 January 2021

73,761

631

74,392

Total comprehensive income for the period

-

533

533

Balance as at 30 June 2021

73,761

1,164

74,925

 

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

FOR THE PERIOD ENDED 30 JUNE 2022 (UNAUDITED)

 

 

The Group

The Company

6 months ended

6 months ended

30 June 2022

30 June 2021

30 June 2022

30 June 2021

USD'000

USD'000

USD'000

USD'000

 

OPERATING ACTIVITIES

Profit before income tax

12,034

7,707

508

533

Adjustments for:

Depreciation of property, plant and equipment

3,203

3,733

-

-

Depreciation of right-of-use assets

823

1,031

-

-

Non-cash items

218

478

(1,090)

(1,030)

Operating Profit/(Loss) Before Working Capital Changes

16,278

12,949

(582)

(497)

(Increase)/ Decrease in:

Inventories

(2,922)

(1,607)

-

-

Trade and other receivables,

(6,444)

(2,175)

(12)

(12)

advances and prepaid expenses

Loans and advances from subsidiary companies

-

-

(24)

(3)

Increase in:

Trade and other payables,

3,494

3,317

56

5

accrued and other liabilities

Cash Generated From/(Used In) Operations

10,406

12,484

(562)

(507)

Income tax paid

(1,785)

(730)

-

-

Interest paid

(198)

(299)

-

-

Net Cash Generated From/(Used In) Operating Activities

8,423

11,455

(562)

(507)

INVESTING ACTIVITIES

Purchase of property, plant and equipment

(2,870)

(4,529)

-

-

Purchase of other assets

(18)

(18)

-

-

Interest received

267

78

1,550

-

Net Cash (Used In)/Generated From Investing Activities

(2,621)

(4,469)

1,550

-

FINANCING ACTIVITIES

Proceeds from borrowings

3,346

3,350

-

-

Repayment from borrowings

(2,815)

(4,089)

-

-

Payment of lease liabilities

(1,090)

(877)

-

-

Net Cash Used In Financing Activities

(559)

(1,616)

-

-

NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS

5,243

5,370

988

(507)

EFFECTS OF FOREIGN EXCHANGE RATE CHANGES

(685)

(114)

-

-

CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD

10,136

8,214

614

1,353

CASH AND CASH EQUIVALENTS AT END OF THE PERIOD

14,694

13,470

1,602

846

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SEFSSMEESEFU
Date   Source Headline
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSAnnual Financial Report
9th Jun 20237:00 amRNSNotice of AGM
13th Apr 20238:00 amRNSMarket update for the quarter ended 31 March 2023
11th Jan 20237:00 amRNSTrading Statement
17th Nov 20224:41 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSDividend Declaration
12th Oct 20227:00 amRNSPurchase of Shares by Substantial Shareholder
12th Oct 20227:00 amRNSPurchase of Shares by Family of Director
7th Oct 20227:00 amRNS3rd Quarter Market Update
26th Sep 20227:00 amRNSHalf-year Report
14th Jul 20227:00 amRNSChange in Holding(s) in Company
14th Jul 20227:00 amRNSResult of AGM
12th Jul 20227:00 amRNSMarket Update - First half of 2022
5th Jul 20227:00 amRNSNotice of AGM and Submissions of Questions
13th Jun 20227:00 amRNSFY2021 Accounts
13th Jun 20227:00 amRNSDividend Proposal and Nomination of Director
13th Jun 20227:00 amRNSNotice of AGM and 2021 Annual Report publication
20th Apr 202210:52 amRNSPurchase of Shares by Substantial Shareholder
13th Apr 20227:00 amRNSMarket Update for quarter ended 31 March 2022
4th Mar 20227:00 amRNSChange in Interests
13th Jan 20227:00 amRNSTrading Update for 2021
12th Nov 20217:00 amRNSStatement re Interim Dividend Policy
8th Oct 20217:00 amRNSSteppe Cement Ltd - 3rd Quarter Results
17th Sep 20217:00 amRNSInterim Results and General Market Update
8th Jul 20217:00 amRNSFinal Dividend FY2020
8th Jul 20217:00 amRNSAGM Results
7th Jul 20217:00 amRNSMarket update for the first half of 2021
7th Jun 20218:01 amRNSFinal Results and Accounts 2020
7th Jun 20218:00 amRNSNotice of AGM + Annual Report 2020
13th Apr 20217:00 amRNSMarket Update for Quarter ended 31 March 2021
19th Feb 20217:00 amRNSHolding(s) in Company
11th Jan 20217:00 amRNSPreliminary Update for the Year ended 31 Dec 2020
29th Oct 20208:00 amRNSDeclaration of Interim Dividend
9th Oct 20207:00 amRNSMarket Update for 3rd Quarter ended 30 Sept 2020
5th Oct 20208:36 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.